# Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients

> **NCT01626469** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Captopril
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01626469
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626469, "Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic Patients". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01626469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*